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1. Introduction 
Gene therapy as an alternative to conventional medicine implies the elimination of the cause 
of a disease via the introduction of therapeutic nucleic acids (antisense oligonucleotide, or 
siRNA, or transgene expressing plasmid DNA, or aptamers, etc) into the cells of the 
organism (Blau & Springer, 1995; Lv et al., 2006; Karmali & Chaudhuri, 2007; Rayburn & 
Zhang R., 2008; and references in it). However, efficient delivery of genes at the 
physiological level into cells of living organism (‘‘transfection’’) is always more simple in 
theory than in practice. Both the therapeutic nucleic acids and cell membrane are negatively 
charged and therefore the spontaneous entry of naked nucleic acid inside cells is unlikely to 
be an efficient process. In other words, the development of clinically viable gene-targeted 
therapeutics and the design of safe and efficient gene delivery reagents (‘‘transfection 
vectors’’) are inseparable problems. (Templeton, Ed. 2010). 
Prior to reaching the nucleus, the therapeutic nucleic acids must overcome a number of 
biological barriers, in particular, the cellular, endosomal, and nuclear membranes. This 
process is achieved by the utilization of appropriate delivery systems, that protect the 
genetic material from the destructive action of enzymes and encourage their penetration 
into the intracellular space, transfer through the nuclear membrane, and further expression 
in the nucleus (Eliyahu et al., 2005). In addition, these delivery systems should be nontoxic, 
non-immunogenic and biocompatible. 
The administration of genes for therapeutic purposes can be  achieved using one of three 
different  approaches. The first approach  consists of a direct injection of naked non-
protected DNA into the cell  resulting in a high level of transgene expression. The simplicity 
of this approach ensures it can be reasonably applied in a number of experimental protocols 
(Huang et al., Eds.; 2005). However, therapeutic application of unprotected naked nucleic 
acids is limited by the easily accessible organs (skin or muscles) for direct injection and is 
not applicable for systemic delivery due to a number of factors, the most important of which 
being extracellular nucleases. Gene-modified viruses and virus like particles represent the 
second approach for the cellular delivery of therapeutic nucleic acids. Viruses are efficient in 
transducing cells. However, the safety concerns regarding the use of viruses in humans 
make non-viral delivery systems an attractive alternative.  
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The third approached is focused upon the use of non-viral vectors. Non-viral vectors are 
particularly suitable with respect to their simplicity of use, large-scale production and 
lack of specific immune response. Non-viral vectors can be grouped into three main 
categories: cationic lipids, cationic polymers, and peptides.  In comparison with their viral 
counterparts, these vectors are currently considerably less efficient, but their well-defined 
physical and chemical composition coupled with their reduced immunogenicity and 
toxicity make them promising candidates for gene delivery (El-Aneed, 2004; Dass, 2002; 
Verma & Weitzman, 2005).  
Another important method of gene delivery is lipofection, a method based on the use of 
cationic lipids/cationic liposomes for gene transfer (Templeton, Ed. 2010; Huang, et al., Eds.; 
2005; Karmali & Chaudhuri, 2007; Tseng et al., 2009). Cationic lipids have many potential 
advantages and have thus been viewed favorably in comparison  with other non-viral 
vectors, including the significant simplicity and ease of production, good repeatability and 
biodegradability, potential commercial value, and their wide range of clinical application 
and safety. 
The cationic liposomes are formed using cationic lipids, comprising a wide range of 
chemical compounds with a common structural feature, namely, the presence of both 
positively charged hydrophilic and hydrophobic domains. Of the most significant interest 
are biodegradable cationic lipids of natural origin (Lv et al., 2006). Long-chain 
hydrocarbons, steroids, and diglycerides are used as the hydrophobic domains (Zhi et al., 
2010). The cationic hydrophilic domain can be represented by one (monocationic lipids) or 
more (polycationic lipids) positively charged groups. Monocationic lipids are most often 
secondary, tertiary or quaternary derivatives of aliphatic or heterocyclic nitrogen bases. In 
polycationic lipids, natural or synthetic polyamines or amino acids are used as the 
hydrophilic domains. The stability and toxicity of cationic lipids in biological systems, are 
determined by the type of bond connecting hydrophobic and hydrophilic domains. 
In addition to cationic lipids, the zwitterionic helper lipid has a major impact upon the 
structure and activity of lipoplexes. A helper lipid can improve the ability of cationic 
liposomes to transfect cells. In vitro studies show that liposomes composed of an 
equimolar mixture of dioleoylphosphatidylethanolamine (DOPE) and cationic lipids 
(DOTMA, DOTAP) can mediate higher levels of transfection than those containing only 
the cationic lipid (Hui et al., 1996; Mok et al, 1997; Kerner et al., 2001). This fact has been 
attributed to the ability of DOPE tendency to undergo a transition from a bilayer to a 
hexagonal configuration under acidic pH, possibly  facilitating fusion with, or 
destabilization of target membranes, in particular endosomal membranes (Zuidam & 
Barenholz, 1998; Zuidam et al., 1999).  
Cholesterol initially used as a helper lipid form more stable but less efficient complexes than 
those containing DOPE in vitro. However, cholesterol containing lipoplexes have shown a 
higher rate of biological activity when compared to lipoplexes with DOPE, when these 
complexes were utilized in vivo (Liu et al., 1997; Sternberg et al., 1998; Smith et al., 1998; 
Simberg et al., 2003). The significant transfection activity attained  was attributed to an 
improved cell binding and uptake of the lipoplexes promoted by the presence of cholesterol 
(Crook et al., 1998) and/or better stability of the lipoplex in serum (Simberg et al., 2003). 
In 1991, Gao et al. reported the synthesis and application of the cholesterol-based cationic 
lipid 3-β-[N-(N′,N′-dimethylaminoethyl)carbamoyl]-cholesterol (DC-Chol, 1a), which was 
combined with DOPE to transfect mammalian cells (Gao & Huang, 1991). Since then, 
considerable endeavors have  been made in the synthesis of steroidal cationic lipids, due to 
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their potential applications in gene therapy (Zhdanov et al., 1998; Gao & Hui, 2001; Choi et 
al., 2001; Geall et al., 2000; Percot et al., 2004; Ding et al., 2008; Medvedeva et al., 2009; 
Maslov et al., 2010). The cationic amphiphiles containing cholesterol as a hydrophobic 
residue possess a high transfection activity and a low toxicity, finding use in the studies of 
both the structure–activity relationships and membrane fusion mechanisms (Noguchi et al, 
1998; Kearns et al., 2008). Found within the synthesized cholesterol derivatives are 
commercially available lipids, (DC-Chol) and N1-cholesteryloxycarbonyl-3,7-diazanonane-
1,9-diamine (CDAN). The liposomes prepared with DC-Chol or CDAN and DOPE lipids are 
widely used to deliver the plasmid DNA for tumor immunotherapy or artificial 
immunization and are under clinical trials for the therapy of mucoviscidosis. 
The efficiency of liposome mediated gene delivery is ascertained not only by the structure of 
cationic and helper lipids, properties of the nucleic acid, but also by the size and ζ-potential 
of the lipoplex formed with the nucleic acid. Therefore, the efficiency of the lipid vehicles for 
nucleic acid delivery is dependent upon the structure of cationic amphiphile whose 
chemical design requires a tailored approach, taking into account the lipid composition of 
the membranes, the nature of cell receptors, and the chemical processes in the intracellular 
environment.  
Thus, in this chapter we summarize recent results on the design and structure-activity 
relationships of cholesterol-based cationic lipids with multiple architectures. We show that 
some of the designed cationic lipids (liposomal formulations) mediate efficient cellular 
accumulation, endosomal escape and the biological activity of the delivered nucleic acids 
(siRNAs, transgene expressing DNA, etc).  
2. Cholesterol-containing cationic lipids and polymers 
2.1 DC-Chol 
Cationic lipid DC-Chol (1a) was originally synthesized by Gao et al. (Gao & Huang, 1991) 
and is available commercially. The DC-Chol was formulated as a cationic liposome with the 
helper lipid DOPE which promotes the fusion of lipoplexes with the cell membrane 
resulting in an increase of the DNA transfection efficiency (Zuidam & Barenholz, 1998; Lin 
et al., 2003). 
Cationic liposomes DC-Chol/DOPE have been used extensively both in vitro and in vivo,  
displaying high transfection efficiencies (TE) (Litzinger et al., 1996; Song et al., 1997; Porter 
et al., 1998). There are documented reports that cationic liposomes DC-Chol/DOPE work 
well in various cell lines e.g. A431 human epithermoid carcinoma cells, A549 human lung 
carcinoma cells, L929 mouse fibroblast cells, YPT minipig primary endothelial cells (Gao & 
Huang, 1991), COS-7 cells, CFNPE-9o and 16HBE14o epithelial cell lines (Caplen et al., 
1995), SKnSH and the primary rat neuronal cells (Ajmani et al.,1999), glioma cells (Esposito 
et al., 2003).  
An experimental study of DNA compaction with the liposomes DC-Chol/DOPE that 
covered the whole range of  mixed lipid composition and several lipid/DNA charge ratios 
was published (Rodriguez-Pulido et al., 2008; Munoz-Ubeda et al., 2010). A series of 
experimental techniques (electrophoretic mobility, SAXS, and fluorescence anisotropy), 
together with a theoretical aggregation-disaggregation model, has  attested to the fact that 
DC-Chol/ DOPE cationic liposomes, with an average hydrodynamic diameter of (120+/-10) 
nm, properly condense and compact DNA and the liposomes composition is a key factor  
pertaining to the properties and structure of the resulting lipoplex.  
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Commercially available, DC-Chol is widely used for the development of  novel approaches 
for DNA delivery,  i.e. as a component of cationic solid lipid nanoparticles (SLNs) (Choi et 
al., 2008). The SLNs for gene delivery composed of DC-Chol, DOPE, and Tween 80 with TC 
(tricaprin) as a core in various ratios were produced by the melt homogenization method. 
The SLNs were bound to the cellular membrane 10 min after transfection, and translocated 
to the cytosol 60 min later. After 24 h, the SLNs were detectable in the nucleus and cytosol. 
SLNs showed high transfection efficiency in comparison with commercially available 
Lipofectin. In fact, PCR analysis indicated that SLNs prolonged the mRNA expression of the 
plasmid in various organs for up to 5 days. The SLNs-mediated transfection of the p53 gene 
resulted in the efficient reestablishment of wild-type p53 function in lung cancer cells and 
restored the apoptotic pathway (Choi et al., 2008). 
The use of the most thoroughly investigated cationic lipids DC-Chol, DOTAP, and 
dimethyldioctadecylammonium (DDA) as vaccine delivery systems to form an antigen 
depot at the site of injection (SOI) and to induce immunological responses in vivo was 
reported (Henriksen-Lacey et al., 2011). DC-Chol, DOTAP, and DDA liposomes 
incorporating immunomodulating trehalose dibehenate (TDB) were prepared. DC-
Chol/TDB liposomes were stable under storage and were retained at a significantly better 
degree  at the SOI, with nearly 40% of the original dose still detectable 14 days p.i,  in 
comparison with DOTAP/TDB liposomes. With regards to the depot effect at the SOI, the 
formulations were able to cause antigen retention  between the range of 59 and 79% of the 
antigen dose recovered one day p.i.  
The key step in lipid-mediated DNA delivery may be the structural changes of lipid carriers 
resulting in DNA release (Tarahovsky et al., 2004; Koynova et al., 2006; Hoekstra et al., 
2007). In recent times, it was shown that multicomponent lipoplexes are superior in 
transfection with respect to the binary ones usually employed for gene delivery (Caracciolo 
et al., 2005a; 2005b; 2006). For instance, the four-component lipid system incorporating 
cationic lipids DOTAP, DC-Chol and neutral helper lipids dioleoylphosphocholine (DOPC) 
and DOPE transfer DNA into mouse fibroblast (NIH 3T3) and tumoral myofibroblast-like 
(A17) cell lines more efficiently than the thoroughly studied DOTAP/DOPC and DC-
Chol/DOPE cationic liposomes separately. To answer the question concerning how TE will 
change with an increasing number of lipid components, the multicomponent lipoplexes 
were studied incorporating three to six lipid species simultaneously and the TE was then 
evaluated with respect to mouse fibroblast (NIH 3T3), ovarian (CHO) and tumoral 
myofibroblast-like (A17) cell lines (Caracciolo et al., 2007). These multicomponent lipoplexes 
exhibited a much higher TE (about two orders of magnitude) than binary lipoplexes that are 
more commonly employed for gene delivery. Furthermore, a trend was discovered that the 
TE increases in correlation with the number of lipid components (with some exceptions as a 
result  of lipid composition). This discovery may be related to the higher fusogenicity and 
compatibility of vesicles composed of several lipid components with respect to single lipids 
(Caracciolo et al., 2007). The existence of different regimes of stability was demonstrated for 
these multicomponent lipoplexes: the most efficient lipoplexes exhibited intermediate 
‘optimal stability’. To this end, lipoplexes DOTAP/DOPC-DNA were the least resistant 
mixture to disintegration; DC-Chol/DOPE/DOPC-DNA, the most resistant mixture to 
disintegration; and DOTAP/DC-Chol/DOPC/DOPE-DNA, the mixture exhibiting an 
intermediated behavior and characterized by a high TE. The extent of DNA release 
estimated by electrophoresis was in total concurrence  with the structural stability of 
lipoplexes revealed by SAXS and TE (Caracciolo et al., 2007). 
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2.2 Monocationic lipids 
The basic structure of the cholesterol-based cationic lipids used in gene therapy includes  
four functional domains: 1) Appositively charged headgroup capable to bind with the 
negatively charged phosphate group of nucleic acid; 2) a hydrophobic cholesterol anchor, 
which interacts with the cellular membrane; 3) a spacer group; 4) a linker group, which 
connects the positively charged head and the hydrophobic domain. 
In order to estimate the contribution of each functional domain into the efficacy of DNA 
delivery and cytotoxicity, various types of cholesterol cationic lipids were synthesized. In 
the first investigation of the structure-activity relationship, it was  revealed that in order to 
achieve  an efficient transfection, the tertiary ammonium group must be connected to the 
cholesterol by a short spacer via the ester or urethane bond. (Farhood et al., 1992).  
In further studies the 3-deoxycholesterol cationic derivatives 2a-с were synthesized, 
which are shown to be more efficient than DC-Chol (1a) or lipid 1b (Takeuchi et al. 1996). 
It was observed that introduction of the ethyl or propyl groups into the cationic head 
results in the decrease of the transfection efficiency (TE). The value of the surface charge 
(ζ-potential) for the liposomes based on lipids 1a,b, 2a-с, 3а and their analogs was in  
positive correlation with TE of the HeLa, COS-7, and NIH 3T3 cells. Cationic liposomes 
2а/DOPE, having the highest ζ-potential, demonstrated the highest TE in all cell lines 
tested.  Furthermore, the activity of the liposomes derived from the compounds 2с and  
3а having the lowest ζ-potential, was less than 20% of the activity of lipid 2а (Takeuchi et 
al., 1996). Moreover, it was found that to achieve an efficient transfection, the size of  
the complexes should be neither smaller (<400 nm) nor larger (>1.4 μm) (Kawaura et  
al., 1998). 
Lipid 2d, containing the 2-hydroxyethyl group was found to be more active than the 
compound 2a with dimethylamine group, both in the presence and absence of serum 
(Okayama et al., 1997). Further modifications of the lipid structure by introduction of 
additional 2-hydroxyethyl groups (compounds 2e-i) into the cationic head resulted in the 
collapse of transfection activity. Similarly, the derivative 2f  containing the primary amino 
group was almost not active. The TE of the lipid 2d was 2-fold higher in comparison with 
the activity of lipids 2a and 2h (Hasegawa et al, 2002). Based on fluorescence resonance 
energy transfer (FRET) it was observed that DNA is released differently from the 
lipoplexes by means of anionic liposomes. Furthermore, both the release rate and the 
amount of unbound DNA have a positive correlation with the TE. The transfection 
efficiency of nanoparticles composed of the lipid 2d was 11.5-fold higher than the TE of 
DC-Chol (1а) and was comparable with Lipofectamine 2000, DMRIE-C and Tfx-20 
(Hattori et al., 2007). The size of the nonoplex was 290 nm, and the highest TE in vitro was 
observed for the nitrogen/phosphate (N/P) ratio of 3, when the nanoplex was positively 
charged. The in vivo delivery directly into the tumor demonstrated that the optimum TE 
corresponds to the N/P ratio of 1; meanwhile the size of nanocomplexes was around 145 
nm, and ξ-potential was negative (-16.9 mV). After the intravenous, intramuscular and 
peroral administration,  there was no transgene expression detected in any organ. 
Lipids containing ester (3b,c), ether (3d-f) and urethane (1b) bonds were synthesized (Ghosh 
et al., 2000; Ghosh et al., 2002) in order to study the influence of linker type on the TE. It was 
subsequently demonstrated, that the presence of the urethane-based linkage in the 
compound 1b led to the 6-fold decrease of the TE, in comparison to the ether lipid 3d. 
However, in our opinion, this kind of comparison is fallacious due to presence of the 
different type of  cationic head in the structure of the lipids 1b and 3d. Cholesterol lipids 
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with the ether linkage 3d,e were significantly more efficient than their analogues 3b,c with 
ester bond. The increase of the spacer length by one oxyethylene unit (lipid 3f) resulted in 
the decrease of the TE. The efficiency of the 3d-based liposomes was comparable with the 
Lipofectamine. Lipid 3e with 2-hydroxyethyl substituent efficiently transected cells without 
DOPE. A comparison of the liposome mediated siRNA delivery in the presence of serum 
was  carried out for the lipids with ether (3g) and urethane (1c) linkage. (Han et al., 2008). 
The cellular accumulation of the fluorescein-labeled siRNA mediated by liposome 1с/DOPE 
was inhibited by serum, while liposomes 3g/DOPE had the ability to efficiently deliver  
siRNA into the cell in the presence of serum. Liposomes 3g/DOPE were successfully applied 
for silencing survivin and green fluorescent protein (GFP). 
A comparative study of the TE of DC-Chol (1a), and lipids 1c-e was performed in order to 
estimate the effect of the cationic headgroup in the cholesterol lipids containing the 
urethane linker group (Kearns et al., 2008). The lipids 1с and 1d, containing both primary 
and secondary amino groups, were able to transport DNA into the melanoma B16-F10 
cells. These data differ from the results received for the 3-deoxycholesterol derivatives 2a-
f, where the lipid 2f with primary amino group display extremely low TE  in comparison 
of the analogue 2a with the tertiary amino group. It was observed  that lipids 1с and 1d 
containing primary and secondary amino groups are less toxic,  in comparison to the 
lipids with tertiary (1a) and quaternary (1e) amino groups. The highest TE achieved for 
liposomes with lipids 1c and 1d could be a result of the ability of these liposomes to 
penetrate into the cells, to interact with the endosomal membrane and to release the 
nucleic acid into the cytoplasm.  
Cationic liposomes formed by lipid 1f in combination with DOPE were able to deliver DNA 
into the cells (Reynier et al., 2002; Lesage, 2002). The TE of these liposomes was 2-fold higher 
in comparison with DC-Chol (1a)/DOPE liposomes. What is more, the TE increased in the 
presence of 4% PEG 8000. Using the liposomes 1e/DOPE and 1f/DOPE (1:1) the relocation 
of DNA within the lipoplexes upon the transfection was monitored  in addition to the 
localization of the plasmid DNA inside the cell nucleus was visualized using immunogold 
labeling (Briane, et al., 2002). 
As mentioned above, the introduction of the 2-hydroxyethyl substituent into the cationic 
headgroup can increase the TE (Okayama et al., 1997; Hasegawa et al, 2002).  The cationic 
lipid 1h was synthesized and formed stable liposomes with DOPE with the monomodal size 
distribution (Percot et al, 2004). In vivo direct injection into the tumor of the liposomes 
1h/DOPE and 1g/DOPE demonstrated that the TE of the 2-hydroxyethyl-containing lipid 1h 
was slightly lower than the TE of the lipid 1g containing trimethylammonium headgroup. In 
order to study the effect of 2-hydroxyethyl group on the TE more thoroughly, the activity 
the lipids 1b and 1h-k was tested  and compared with the activity of DC-Chol (1a) and 3-
deoxycholesterol derivative 2d (Ding, et al., 2008). It was discovered that lipids without Ǽǻ-
groups (DC-Chol and 1b) had the higher TE in comparison with the 2-hydroxyethyl-
containing lipids 1h-k, excluding lipid 2d. Liposomes 2d/DOPE possessed the highest TE in 
vitro (comparable with Lipofectamine2000) when N/P ratio was equal to 3, and were 
characterized by the big sizes of both liposomes itself (400 nm) and lipoplexes. The maximal 
level of the luciferase gene expression in vivo after intratracheal administration of the 
lipoplexes 1k/DOPE-pDNA was 2-fold higher than the levels for the 1h/DOPE, 1j/DOPE  
and 4-fold higher than for DC-Chol (1a)/DOPE. The liposomes containing lipid 2d were the 
least active. 
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It was found that heterocyclic cationic lipids containing imidazolinium (Solodin et al., 1995) 
or pyridinium polar heads (Ilies et al., 2006) reveal a higher TE and a reduced level of 
cytotoxicity in comparison with the classical transfectants. To study the influence of  this 
type of heterocyclic polar head on the TE, the cholesterol-based lipids containing 
heterocyclic amine connected to the cholesterol residue via urethane (4a-f, 6a), ether (5a-5h) 
and ester linkers (6b-f) were synthesized (Gao & Hui, 2001; Bajaj et al., 2008c; Medvedeva et 
al., 2009). 
The study of the transfection activity for the lipids 4a-f revealed that liposomes 4c/DOPE 
and 4f/DOPE displayed the highest TE, which from 3 to 6-fold exceeded the TE of DC-Chol 
(1а)/DOPE and Lipofectamine 2000 (Gao & Hui, 2001). The serum (from 1 to 10%) have no 
effect on cells transfection mediated by these cationic liposomes at different N/P ratios. It 
was observed that these liposomes gained a negative charge in the presence of serum. In 
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vivo DNA delivery (direct administration into the spleen) was efficient at low N/P ratios, 
but  as yet, no reasonable explanation for  this occurrence has been found. 
Liposomes formed from lipids 5a-g and DOPE were able to transfect 50-80% of cells, and the 
TE increased when the N/P ratio increases (Bajaj et al., 2008c). The highest TE was observed 
for lipid 5f containing N,N-dimethylaminopyridinium headgroup. This lipid transfected 
cells in the presence of serum without any loss of activity. The experiments with sodium 
dodecylsulphate (SDS)-induced DNA release from the lipoplexes demonstrated that DNA is 
released from the complex with liposomes 5f/DOPE in an unhurried manner. This could 
possibly be a result of a more effective lipid shielding of DNA. This is probably a reason for 
the high TE displayed by liposomes 5f/DOPE, even in the presence of the serum. 
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The structure-activity relationships study for the series of lipids 6a-f,  containing different 
heterocyclic cationic groups and linkers, permitted us to determine that lipids containing 
pyridinium (6a,b) or N-methylimidazium (6d) heads and ester or urethane linkers are the 
most promising in terms of transfection (Medvedeva et al., 2009). It was also revealed, that 
the ability of these lipids to deliver the oligodeoxyribonucleotides and pDNA into cells, 
correlates positively with their ability to form lipoplexes with the size not exceeding 100 nm. 
Cholesterol-based lipids containing heterocyclic polar heads linked via biodegradable 
β-glucosyl spacer were prepared (Maslov et al., 2010). 
The study of the biological activity of the cationic glycolipids 7a-d demonstrated that nucleic 
acids could be efficiently delivered only by means of cationic liposomes; however this was 
www.intechopen.com
Non-Viral Gene Delivery Systems Based on  
Cholesterol Cationic Lipids: Structure-Activity Relationships 
 
357 
not possible using individual lipids. The delivery of fluorescein-labeled oligonucleotide was 
comparable for the liposomes 7d/DOPE and Lipofectamine 2000. In the case of the siRNA 
delivery, the highest TE was observed for the liposomes 7c/DOPE and the GFP gene-
silencing was observed both in the absence and in the presence of serum in the culture 
media. 
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2.3 Stimuli-responsive cationic lipids 
It was revealed that lipoplexes enter the cells via nonspecific endocytosis, which occurs after 
the electrostatic binding of the positively charged lipoplexes to the negatively charged 
components of the cell membrane (Rejman, et al., 2006; Belting et al., 2005). There are a 
number of obstacles, hindering the efficient cationic liposome-mediated gene transfection: 
DNA release from the endosomes, DNA dissociation from the lipoplexes (Escriou et al., 
1998; Rolland, 1998; Zabner et al., 1995) as well as insufficient release of DNA from 
endosomes. The use of stimuli-responsive delivery systems offers a new opportunity for the 
improvement of the delivery of nucleic acid (Ganta et al., 2008). Therefore, pH and redox 
microenvironment can be used as biological stimuli to improve the TE of lipoplexes. To 
achieve a stimuli-responsive release of DNA it is necessary to design cationic lipids 
containing trigger-groups, which specifically react to the alteration of the pH value, or to the 
presence of the intracellular reducing agents. 
2.3.1 Redox-responsive disulfide cationic lipids 
Thiol-disulfide exchange reactions play an important role in the biological functions of 
living cells; notably in the stabilization of the protein structure and redox cycles. The strong 
intracellular reductive micro-environment can stimulate the disintegration of the lipoplexes 
if these compounds contain the disulfide cationic lipids that are stable outside the cells, but 
could be reduced in the cells by intracellular reductive agents, e.g. glutathione (Tang & 
Hughes, 1998). The reduction of the disulfide bond will enhance the release of DNA from 
the DNA-liposomes complexes. Previously, it was demonstrated that the transfection of the 
plasmid DNA by the glycerolipids containing disulfide bonds was higher compared to the 
transfection activity of its non-disulfide analogue (Tang & Hughes, 1998). 
Lipid 8a containing cholesterol, was synthesized and its activity to mediate DNA transfer 
was compared with the activity of both non-disulfide analogue 8b and DC-Chol (1a) (Tang 
& Hughes, 1999). In the presence of glutathione (10 mM)  a 50% DNA release from the 
complex with liposomes 8а/DOPE was observed, while the lipoplexes formed by lipid 8b 
did not release DNA. The TE for the disulfide lipid 8а was 100-fold higher,   in comparison 
with the DC-Chol (1a) and 7-fold higher when compared to the lipid 8b, in spite of the fact, 
that the amount of DNA internalized by cells was lower in the case of 8а. 
Lipids 9a-c based on thiocholesterol (in the mixture with DOPE) were more active in 
comparison to PEI and DOTAP/DOPE when transfecting CV-1 cells (Huang et al., 2005). 
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Nanolipoparticles (NLP) were formed from lipids 9a-c and PEG was added for the steric 
stabilization. The treatment of NLP with cysteine or glutathione changed the surface charge 
of the particles; the modification of the NLP surface with Tat-protein resulted in the increase 
of the TE of the neutral and negatively charged NLP. 
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To find new efficient transfectants, the water-soluble low-toxic cholesterol-based lipids 
10a-d were synthesized. The lipids contain the positively-charged headgroups connected 
to the cholesterol backbone via the disulfide and carbonate linkers (Sheng et al., 2011).  
The atomic force microscopy indicated that mixing the cationic lipids and DNA gave 
compact, condensed lipoplexes with a size 200-300 nm. The addition of dithiotreitol (10 
mM) resulted in the disassembly of these complexes into tiny, irregular-shaped fragments 
and small sized pieces, confirming the cleavage of  disulfide bonds and distortion of  
the stable lipoplexes. Lipid 10c, which contained the natural aminoacid lysine, displayed 
the highest TE in respect to COS-7 cells, both in the presence and absence of serum. The 
least active was lipid 10b with the quaternary amino group. It is worthy of note, that lipid 
10a was almost as active as 10c at low N/P ratio (up to 5). This ratio is characterized by 
the formation of the small lipoplexes (approximately 250 nm) with the negative  
ξ-potential. 
2.3.2 pH-responsive cationic lipids 
It is known that endocytosis is accompanied by a noticeable increase in the environment 
acidity from the physiological value of pH 7.4 to 6.5–6.0 in endosomes and to 5.0 in primary 
or secondary lysosomes (Mukherjee et al., 1997). Endocytosed lipoplexes may  be digested 
by acidic hydrolases,  active at the acidic pH of the lysosome. In order to protect DNA from 
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such hydrolytic degradation and enhance the release of DNA from endosome pH-sensitive 
cationic lipids were synthesized (Budker et al., 1996). These lipids contain weakly basic 
lysosomotropic imidazole head group which acts as a proton sponge, preventing the 
acidification of endosomal environment and  inhibiting the degradative hydrolysis. Another 
approach to enhance the DNA release is the incorporation of the chemical trigger-bond into 
lipid that could be hydrolyzed at a specific pH gradient. Therefore, incorporation of acid-
labile bonds into the lipid structure favors the lipoplex destabilization and facilitates the 
DNA release from the endosomal compartment to the cytoplasm, thus improving the 
transfection efficiency (Boomer et al., 2002; Guo & Szoka, 2003). Furthermore, the use of 
biodegradable cationic lipids lowers the cytotoxicity of cationic liposomes,  making them 
promising transfection agents. 
 
 
 
Cholesterol-based, endosomal, pH-sensitive, histidylated, cationic lipid (11a), its less  
pH-sensitive analogue with the electron-deficient head group (11b) and cationic lipid,  
which does not contain histidine headgroup (11c) were synthesized (Singh, et al.,  
2004). Lipid 11b exhibited lower TE than lipid 11a in  relation to 293T7 cells. The activities of 
both lipids were inhibited in the presence of Bafilomycin A1, demonstrating the 
involvement of imidazole ring protonation in the endosomal escape of DNA. However, the 
TE of histidinylated lipid 11a did not exceed this value for lipid 11с. The lipid 12 with an 
acid-sensitive ketal bond was hydrolyzed in acidic medium where an ether analogue 
remained undegraded (Zhu, et al., 2002). Lipid (12) achieved levels of gene delivery similar 
to DC-Chol (1a), but the toxicity was correspondingly low. 
In recent time a new series of cationic steroid derivatives, containing guanidinium 
headgroup connected with the hydrophobic cholesterol via the acid-sensitive 
acylhydrazone linker have been developed (Aissaoui et al., 2004). The lipid 13a was found 
to possess a low cytotoxicity and was able to mediate the efficient gene transfection into 
various mammalian cell lines in vitro. The TE of the lipid 13а was comparable with TE of 
its analogue 13b, which did not contain the acid-labile group. Colloidally stable 
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13a/DOPE-DNA complexes were prepared and administered via nasal instillation into the 
mouse airways. A significant expression of the reporter protein in the lung homogenates 
was subsequently detected. It should be noted, the TE in the experimental groups was 
much higher compared to the control group of mice receiving the identical dose of 
“naked” DNA. 
2.4 Cholesterol gemini-surfactants 
Recently, a new class of surfactants was discovered.  These so-called ‘dimeric’ or ‘gemini-
surfactants’ attract a considerable amount of scientific attention as being of particular 
importance in biology. For instance, the ability to form “bilayer bridges”was demonstrated 
for some gemini-surfactants containing long hydrophobic spacers (Moss & Li, 1992). The 
structure of these gemini-surfactants resembles the structure of lipids found in the 
membrane of the thermophiles archaebacteria. Other gemini-surfactants were specially 
synthesized for the usage as nucleic acids carriers into the cells (Kirby et al., 2003;) and the 
effects of the nature of the spacer, hydrocarbon chains, and headgroups on the transfection 
activity of these compounds were studied in  detail. 
Dimeric lipids 14a-k, differing in the length of the spacer and the type of the cationic 
headgroup, were synthesized, and the transfection activity of these compounds was 
compared with this parameter for the monomeric lipids 3d and 3e (Bajaj et al., 2007a; Biswas 
et al., 2011). Lipids formed different aggregates, depending on the structure of the cationic 
head. For instance, individual vesicles with sizes from 20 to 160 nm were formed by the 
compounds 14a-e. In turn, for lipids 14f-k formation of vesicular conglomerates of various 
lengths composed of the individual vesicles was observed. These conglomerates were 
formed due to the hydrogen bonding interactions imposed by the 2-hydroxyethylated 
headgroups of the lipids of each vesicle of geminies 14f-k (Biswas et al., 2011). The maximal 
TE was observed for the lipid 14с, containing pentamethylene spacer, and, on the contrary, 
lipid 14e was not active in the absence of serum in the culture media. A different 
morphology of the lipoplexes formed by these lipids and DNA was subjected to further 
study. Transmission electron microscopy showed the presence of the aggregates with the 
size range from 100 to 200 nm for the lipoplexes formed by 14c, while lipid 14e was found to 
form lipoplexes of irregular shapes and sizes.  
The replacement of the hydrophobic spacer by hydrophilic one led to the new set of dimeric 
amphiphils 15a-d possessing low toxicity. The amphiphiles 15a,b were able to transfect  
the cells at the low N/P ratio, as well as in the presence of 30 and 50% serum (Bajaj et  
al., 2007b). 
Due to the fact that lipids with ether bond are poorly degraded in the organism, new 
disulfide bond containing dimeric lipids 16a-c were synthesized, able to degrade under the 
influence of intracellular reducing agents (Bajaj et al., 2008a). These lipids contain flexible 
hydrophobic and hydrophilic spacers,  in addition to  rigid hydrophobic spacers. The 
comparative analysis indicated that the TE of the lipids is  decreases in the range 16с > 16a > 
16b. Thus, the hydrophilic flexible spacer in the lipid structure is essential for an effective 
transfection. The serum inhibited the activity of the lipids 16a-c, as its negatively charged 
components compete with DNA for the binding to the cationic lipids, which results in the 
dissociation of the complexes and a decrease of the TE. In recent times, a new method for 
the synthesis of the dimeric lipids 17а-с that contain cholesterol and spermine moieties and 
potentially posses the high TE was described (Petukhov et al., 2010). 
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2.5 Polycationic lipids 
Polycationic lipids contain a polar head that bears  either several or multiple positive 
charges  increasing their affinity to nucleic acids. Polyamines were successfully used as a 
component of polycationic lipids (Geall et al., 2000; Blagbrough et al., 2003; 2004; Oliver et 
al., 2004). Polyamines are a class of naturally occurring compounds that display excellent 
nucleic acid binding and condensing properties. It is well known that the overall positive 
charge of the lipoplexes is important for initiating cell entry and release of the complexed 
nucleic acid into the cell cytoplasm. Although the exact mechanism by which polycationic 
lipids mediate transfection requires more detailed investigation evidence in literature points 
towards the notion that the success of these reagents arises from a couple of factors: the 
abnormally low pKa’s (pKa <7) of the polyamines, a direct result of the number of amino 
groups present and the methylene spacings between them (Stewart et al., 2001; Keller et al., 
2003; Geall et al., 1999; 2000). 
The effects of the regiochemical distribution of positive charges along the polyamine moiety 
in DNA condensing agents were studied (Geall et al., 2000). DNA condensation is 
dependent upon the number of positive charges, the regiochemical distribution of charges of 
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polyamines (determined by the pKa of each amino group), and the local salt concentration. 
A series of polyamine carbamates of cholesterol was prepared where both the charge and its 
regiochemical distribution have been varied along the polyamine moiety (18a-f) (Geall et al., 
1999). Lipids 18a-f were tested for transfection competence at three different N/P ratios 
(0.5:1, 1:1, 4:1), calculated taking into account the average charge per molecule at pH 7.4. It 
was found that the spermine based lipid 18a, incorporating 3-4-3 methylene spacing along 
the polyamine moiety, has the highest TE, while lipid 18f display the lowest TE. Geall and 
co-workers supposed  that the four methylene spacing found in spermine, could have 
significant implications for DNA polyamine association and lipoplex formation.  
 
 
 
Recently second generation cationic liposomal systems that were formulated from 
polyamine analogues of DC-Chol and DOPE have been described (CDAN (18d), CDAD 
(18a), CTAP (18g), CTAH (18h)) (Cooper et al., 1998). Among the liposomal formulation 
tested the formulation from the novel pentaamine amphiphile CTAP (18g) and DOPE were 
shown to be approximately 400 times more efficient at mediating gene delivery to a mouse 
lung in vivo than DC-Chol/DOPE liposomes. CDAN (18d) is another cholesterol-based 
polyamine lipid with an unnaturally occurring 2–3–2 methylene spacing, which, in 
combination with DOPE forms an exceptionally effective transfection agent. Biophysical 
analyses show that CTAP/DOPE liposomes are effective in vivo because these liposomes are 
able to efficiently neutralise, condense and encapsulate nucleic acids into lipoplex particles 
and the unprotonated amine groups (pKa < 8) presented in the polyamine at neutral pH that 
could have the capacity for endosome buffering, thereby facilitating nucleic acid escape 
from endosomes into the cytosol, like polyethylenimine (Stewart et al., 2001). 
Recently a new solid-phase strategy to synthesize a library of cholesterol-based polyamine 
lipids in excellent yields (>87%) and purity was set forth (Oliver et al., 2004). The strategy 
employs 2-chlorotrityl chloride resin as a solid support and protecting group for one 
primary amine on the starting material, utilizing the high selectivity of 2-acetyldimedone as 
a protecting group for the second primary amine (Oliver et al., 2004).  
Cationic liposomes CDAN (18d)/DOPE were tested as delivery systems for siRNAs 
(Spagnou et al., 2004). The results show that CDAN and DOPE with and without siRNA 
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confer low toxicity to mammalian cells. CDAN/DOPE-siRNA complexes exhibited a slower 
cellular uptake than Lipofectamine2000 based formulations. Intracellularly CDAN/DOPE-
siRNA complexes appear to behave in a different fashion, accumulating in distinct but 
diffuse small non-lysosomal compartments for at least 5 h after transfection (Spagnou et  
al., 2004).  
Recently, a new hepatotropic nontoxic lipid-based vector system for delivering chemically 
unmodified siRNA to the liver to inhibit Hepatitis B virus (HBV) propagation was described 
(Carmona et al., 2008). These anti-HBV formulations were created based on synthetic, self-
assembly ABCD nanoparticle paradigm (Kostarelos & Miller, 2005). ABCD nanoparticles 
comprising nucleic acids, such as plasmid DNA (pDNA) or siRNA (A component) which 
are condensed with cationic liposomes (B component) to form AB core nanoparticles. An 
important feature of the assembly is the incorporation of an aminoxy cholesteryl lipid into 
these AB core nanoparticles  in order to enable the quantitative chemoselective post-
coupling of biocompatibility polymers (C component) and optional tissue-targeting ligands 
(D component) to the core nanoparticles. (Carmona et al., 2008). AB nanoparticles (70-80 nm 
in diameter) were initially formulated in an aqueous solution by mixing of siRNAs with 
cationic liposomes CDAN (18d)/DOPE/19a (40:50:10 molar ratio) or CDAN/DOPE/19b 
(40:50:10 molar ratio).  
 
 
 
Polyethylene glycol2000-dialdehyde (C component), was coupled to AB particles under 
aqueous acidic conditions (pH 4). This surface post coupling was facilitated by a rapid, 
quantitative chemoselective aminoxy-aldehyde conjugation between the aminoxy functional 
group of aminoxy cholesteryl lipid and of the aldehyde functional groups of the C-
component. The resulting oxime linkages are robust at pH 7; however at a level of pH 5.5 
and below, they are prone to decomposition. The developed vectors administered 
intravenously, efficiently deliver unmodified siRNAs to murine livers leading to the strong 
suppression of HBV replication (Carmona et al., 2008).  
The conjugates of guanidinium and cholesterol were synthesized with the yields of up to 61%, 
with  the  purpose of further  improving the  polar domain of cationic lipids (Vigneron et al., 
1996). The guanidinium group can form with phosphate anions characteristic pairs stabilized 
by parallel zwitterionic hydrogen bonds. Moreover, the guanidinium group is also able to 
develop hydrogen bonding with nucleic bases, especially with guanine. The tertiary amine of 
compound 13b, which is situated between two positive guanidinium groups and has probably 
a lower pKa, could also be able to buffer the acidic environment of late endosomes and of 
lysosomes, hence protecting the DNA against degradation. The lipid 13b can be used in vitro 
without DOPE, and this permits the avoidance of the liposomes preparation step. Commonly 
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used for the transfection 13b-DNA complexes were found to form ordered aggregates 
characterized by a fingerprint-like structures, but not the concentric multilamellar vesicles 
demonstrated for the 13b/DOPE–DNA complexes (Pitard et al., 1999).  
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The analysis of transfection of a wide range of cell lines with 13b/DOPE-DNA complexes 
revealed the high efficiency of this process, which is comparable with the commercially 
available transfectants and 10–20-fold exceeds the calcium phosphate precipitation protocol 
(Vigneron et al., 1996; Ouderhiri et al., 1997). Mediated by guanidinium-cholesterol lipids 
gene transfection is appropriate for the mammalian airway epithelium (Ouderhiri et al., 
1997). The positive results of the transfection into primary human cells in vitro and into the 
mouse airways cells in vivo confirm the potential of the cationic lipids   in relation to lung-
directed gene therapy. 
Aminoglycosides, natural polyamines that are known to bind to nucleic acids, represent a 
favorable scaffold for the synthesis of a variety of cationic lipids. The synthesis of a cationic 
cholesterol derivative of kanamycin A and its polyguanidinylated derivative was recently 
described (Belmont et al., 2002). The amino-sugar-based cationic lipid 20a demonstrated  a 
high level of TE in terms of gene transfection of a variety of mammalian cell lines when used 
either alone or as a part of a liposomal formulation with helper-lipid. In addition, colloidally 
stable kanamycin-cholesterol/DOPE lipoplexes were found to be efficient for gene 
transfection into the mouse airways in vivo. 
Designed cholesterol-based kanamycin A analogues (20b,c) bearing various linkers between 
the aminoglycoside headgroup and the cholesterol moiety were prepared (Sainlos et al., 
2005). It was successfully shown, that the length and nature of the spacer can affect the 
physicochemical and biological properties of the lipoplexes. The incorporation of a longer 
spacer into the structures of cholesterol derivatives of kanamycin A can yield the lipoplexes 
with improved in terms of TE physicochemical properties. The cholesterol derivatives 20b,c 
were successfully used for the transfection of mouse airway epithelium in vivo. But the 
beneficial effects of the longer spacers observed in vitro with 20b,c were not found in vivo, as 
only 20c yielded levels of transgene expression higher than those obtained with 20a.  
2.6 Colesterol-PEI conjugates 
Polyethyleneimine (PEI) is polycation widely used for DNA compaction and delivery. The 
high transfection efficiency of PEI was firstly demonstrated by Behr and co-workers (Boussif 
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et al., 1995). PEI is well-known for its ability to compact DNA and to facilitate its early 
endosomal release, preventing the delivered DNA from degradation in the late endosomes 
(Kichler, 2004). The reason for the good transfection activity of PEI is the presence of the 
primary, secondary, and tertiary amino groups. These groups have different pKa values, 
which give the PEI a good buffer capacity, therefore not allowing a decrease in the pH value 
in the early endosomes (Kichler, 2004). 
In literature several kinds of the PEI-cholesterol conjugates have been described. Kim and 
co-workers (Han et al., 2001) synthesized water-soluble lipopolymer (WLSP (21a)) in the 
reaction of the branched PEI (mw 1.8 kDa) and cholesteryl chloroformate. The average 
molecular weight of WSLP (21a) was approximately 2 kDa and the extent of modification 
with cholesterol was ~ 0.5. The WSLP (21a)-pDNA complexes were characterized by low 
toxicity in vitro and they induced the aggregation of erythrocytes to a lesser extent, as 
compared to PEI 25 kDa. WSLP (21a)-pDNA complexes demonstrated higher TE in both 
CT-26 and 293 T cells compared to PEI 25 kDa- or PEI 1.8 kDa-based formulations. As an 
experimental model for the estimation in vivo of the biological activity the authors used the 
antitumor activity of IL-12 coded by the pDNA transfected into the tumor cells. As a result 
of the injections of the WSLP (21a)-pDNA complexes into mice tumors a significant decrease 
in the tumor growth rate (~20% higher, as compared to the administration of the naked 
DNA) and of the level of metastasis formation were observed; resulting in higher survival 
rates of the animals after treatment (Mahato et al., 2001; Janat-Amsbury et al., 2005). Later 
data confirming the high efficacy of WSLP (21a) for the transfection of siRNA in vitro and in 
vivo were obtained (Kim et al., 2007). 
The same authors endeavored to design a more effective transfection reagent based on 
branched PEI (bPEI) using chemically protected primary amine and conjugation of 
cholesterol at the secondary amino groups of PEI. However, contrary to expectations, the 
presence of the non-modified primary amino groups only resulted in a slight increase (1.5-
fold) of the TE (Wang et al., 2002). 
Kim and co-workers obtained partially contradictory data (Kim et al 2001). In this work a 
simple one-step synthetic procedure was used to yield myristyl and cholesterol derivatives 
of PEI having molecular mass 2 kDa. According to the obtained data these modified PEI 
efficiently transfected cell in vitro and displayed lower toxicity when compared to bPEI 2 
kDa; however the compounds were less tolerated by cells than the parent bPEI 2 kDa.  
Fewell and co-workers studied the properties of the PPC conjugates, containing the bPEI 
1.8 kDa, cholesterol and PEG, where the PEGylation extent varied from 0.6 to 20 PEG 
molecules to one bPEI molecule (Fewell et al., 2005). The highest transfection efficiency in 
vivo was observed for the PPC conjugate, where the molar ratio bPEI:cholesterol:PEG was 
1:1:2. When using the conjugates containing a large quantity of PEG molecules, a  decrease 
of the reporter gene expression was observed. The variation of the number of the cholesterol 
residues in the conjugates was not performed: all the tested conjugates contained the bPEI 
and cholesterol at the ratio of 1:1. In order to study the TE of these molecules in vivo the 
authors used a biological model similar to the one described in (Mahato et al., 2001) and also 
demonstrated the efficient inhibition of the tumor growth.  
Furgeson and co-workers also used linear PEI for the synthesis of new cholesterol-containing 
conjugates apart from bPEI. The polymer, obtained in the reaction of a low molecular weight 
lPEI (423 Da) with cholesterol chloroformate, was used for the preparation of the water 
insoluble liponanoparticles using DOPE as a lipid-helper (Furgeson et al., 2002). The in vitro TE 
of nanoparticle-pDNA complexes was ~4-fold higher, in comparison with  bPEI 25 kDa. 
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T-shaped and L- (linear) shaped PEI 25 kDa conjugates with cholesterol (PEIC) were 
synthesized and thoroughly studied, revealing the improved transfection and reduced 
cytotoxic effect, partially a result of the  sequestering of charged secondary amines of PEI, in 
the presence of cholesterol moiety (Furgeson et al., 2003). The modification extent of the PEI 
carrier in this study ranged from 1 to 2 cholesterol molecules per PEI. Polyplexes, formed by 
L- and T shapes PEICs with DNA possessed a higher TE in vitro, in comparison  with the 
initial linear polymer; as well as the bPEI with the same molecular weight. The highest TE 
among the compounds tested was observed for L-PEIC: the expression of the reporter gene, 
delivered into the Renca cells using this conjugate was 32-fold higher in comparison with 
the expression observed in the presence of bPEI. The authors proposed that the differences 
in the TE depended on the conformational changes of the PEI molecule in the presence of 
the hydrophobic substitues. It was shown that the PEIC conjugates penetrated into the cells 
via the interaction with LDL receptors. The high TE of the LPC was confirmed in vivo in 
experiments with systemic and local administration of the polyplexes (Furgeson et al., 2004)  
Multiple modifications of PEI’s amines were commonly avoided, due to the importance of 
the cationic charge for DNA condensation and buffering capacity of the polymer. Therefore 
quantitative data characterizing the impact of cholesterol conjugation was not yet available.  
In connection with this, we attempted to find the optimal extent of modification of the 25 
kDa PEI with cholesterol. Conjugates of PEI bearing a different number of cholesterol 
residues with 0.5 to 20% of amines modified were synthesized. We found that a small 
number of cholesterols attached to PEI (extent of modification was 0.5 or 1%) significantly 
increased the TE of the polymer, while extensively modified PEI-cholesterol conjugates 
demonstrated reduced TE, although possessing lower cytotoxicity (Gusachenko (Simonova) 
et al, 2009). TE studies were performed using different types of biologically active nucleic 
acids: single stranded oligonucleotide, plasmid DNA and siRNA duplex. The most 
promising conjugates in the series were found to be PEIC 0.5 and PEIC 1 demonstrating the 
best combination of TE with lower cytotoxicity.  
The aforementioned PEI-cholesterol conjugates were prepared in the reaction of PEI, having 
various molecular weights and cholesteryl chloroformate. The PEI-lipid conjugates (21b) 
based on ether-linked cholesterol units were first described by Bhattacharya and co-workers 
(Bajaj et al., 2008b). Nine PEI-cholesterol-based conjugates having polymer amine backbone 
linked to the cholesterol unit via the ether link were synthesized. Three low molecular 
weight PEIs were used for the synthesis of these lipopolymers. The TE studies in HeLa cells 
showed a high potency and low cytotoxicity of these lipopolymers in comparison with the 
commercially available PEI. The TE of PEI 25 kDA decreased in the presence of a high 
percentage of serum, whereas PEI-cholesterol-based lipopolymers were discovered to be 
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effective, even in the presence of 50% of serum. The TE and cytotoxicity of the lipopolymers 
were found to depend on the percentage of cholesterol moieties and the molecular weight  
of PEI used for the synthesis of lipopolymers. Optimized lipopolymer-DOPE formulations 
exhobited a higher cell viability and high TE, which was unaffected by serum: the TE of  
the lipopolymers was obviously one of the highest among known non-viral delivery 
systems.  
3. Physico-chemical properties of lipoplexes and their influence on the 
transfection efficiency 
It is commonly known, that the efficiency of liposome-mediated gene delivery is determined 
not only by the structure of cationic and helper lipids or properties of the transfected 
plasmids, but also by the size of the lipoplex and its ζ-potential. The structure of the 
supramolecular DNA–lipid complexes is dependent upon both the external (pH, degree of 
hydration, temperature, and the presence of doubly charged cations, i.e., Ca2+, Mg2+) and 
internal factors. The physico-chemical properties can alter the lifetime, distribution, and the 
TE efficacy of lipoplexes. Thus, in order to shed more light on the mechanism of transfection 
and to elucidate the structure-activity relationships, it is necessary to investigate a number 
of physico-chemical parameters of the lipoplexes. 
Using a set of physico-chemical methods, it was demonstrated that condensation and 
compactization of DNA by DC-Chol (1a)/DOPE cationic liposomes is a result of a strong 
entropically-driven surface electrostatic interactions. Fluorescence anisotropy results have 
revealed that low cationic lipid contents in the liposomes tend to favor more fluid bilayers; 
which in turn are potential advantages for transfecting cells. DC-Chol/DOPE-DNA 
lipoplexes are represented by supramolecular complexes with a different morphology: 
DNA-coated unilamellar lipoplexes, lipoplex nanostructures with thickened, flattened, and 
deformed walls, and also multilamellar lipoplexes with or without open bilayers 
(Rodriguez-Pulido et al., 2008). The effects of hydration and temperature on the structure of 
DC-Chol/DOPE–DNA lamellar lipoplexes were also investigated (Pozzi et al., 2006).  
The DNA complexation and condensation properties of two established cationic liposome 
formulations, CDAN (18d)/DOPE (50:50, m/m; TrojeneTM) and DC-Chol (1a)/DOPE (60:40, 
m/m), were studied by means of biophysical methods (Keller et al., 2003). The results 
provide a suitable framework for the understanding of why CDAN/DOPE cationic 
liposomes are exceptionally efficient, in comparison with other cationic lipid-based systems, 
at mediating cell transfection. The liposomes CDAN (18d)/DOPE formed the metastable 
lipoplexes, exhibiting greater transfection efficiency in vitro in the presence of 10% serum,   
in comparison to DC-Chol/DOPE liposomes. This metastability may be related to  
the unusually low pKa value of 5.7 of amino groups. In addition, it was supposed that 
CDAN (18d)/DOPE-pDNA particles may have a greater tendency to interact with 
negatively charged serum components and facilitate the DNA release from endosomes 
(Keller et al., 2003).  
A critical factor in the lipid-mediated gene delivery is the structural  and phase evolution of 
lipoplexes upon interaction and mixing with anionic cellular lipids (Tarahovsky et al., 2004; 
Koynova et al., 2005, 2006; Koynova & MacDonald, 2007). Such a structural rearrangement is 
supposed to play a central role in the DNA escape process;  i.e. how DNA dissociates from 
lipoplexes and is released into the cytoplasm. The structural and phase evolution of 
lipoplexes upon interaction with lipid mixtures similar to real membranes and DNA release 
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were investigated using liposomal formulations DC-Chol/DOPE, DC-Chol/DMPC, 
DOTAP/DOPC, DOTAP-DLPC, DOTAP/DOPE, prepared at different molar ratia. (Pozzi et 
al., 2009). It was shown that the most unstable lipoplexes (DOTAP/DOPC/DNA) rapidly 
release DNA, while the most stable ones (DC-Chol/DOPE/DNA) exhibit a lower degree of 
DNA release. Therefore, the results can be generalized as follows: the higher the structural 
stability, the lower the extent of DNA release. Using the SAXS technique it was 
demonstrated that the dilution of the DNA lattice takes place upon lipoplex interaction with 
anionic lipids, which is unequivocal proof of the charge neutralization of cationic lipids  
by anionic membranes (Banchelli et al., 2008; Lundqvist et al., 2008). Upon further 
interaction, disintegration of lipoplexes by anionic lipids as well as the formation of 
nonlamellar phases in lipoplex/anionic lipids mixtures are strongly affected by the shape 
coupling between lipoplexes and anionic lipids. Furthermore, coupling between the 
membrane charge densities of lipoplexes and anionic membranes contributes greatly to 
regulating the evolution of lipoplexes/anionic lipids mixtures and the release of plasmid 
DNA (Pozzi et al., 2009). 
3.1 Influence of size 
The data found in literature, describing the influence of the size of lipoplexes on the TE are 
contradictory. A number of researchers have argued that either size of the formed lipoplexes 
is not associated with TE, or that TE is not affected by initial lipoplex size (Han et al., 2008; 
Kearns et al., 2008; Malaekeh-Nikouei et al., 2009). Some researchers posit that large 
lipoplexes possess higher TE in comparison to the smaller ones. For instance, Ross et al. 
demonstrated that TE and cell uptake increased with the increase of the size of lipoplexes 
(Ross & Hui, 1999). The study of the CDAN(18d)/DOPE liposomes demonstrated the ability 
of the liposomes to form large complexes with plasmid DNA, which are characterized by 
the tendency for the sedimentation on the cell surface resulting in the increase of the TE 
(Keller et al., 2003). When siRNA was used as cargo for delivery into cells, the lipoplexes 
with a size between 60 and 400 nm were obtained and no influence of the lipoplex size on 
the efficacy of gene knockdown was observed (Spagnou et al., 2004). It was previously 
reported by Kawaura et al. that vesicles of a moderate size (0.4-1.4 micron) exhibit higher TE 
in terms of gene delivery (Kawaura et al., 1998). The data supporting the higher TE of the 
large lipoplexes were also reported by other researchers (Ding et al., 2008).  
When the formation of complexes has been performed in physiological ionic strength 
conditions, compared with 40 mM Tris buffer, the size of lipoplexes can be significantly 
increased  (Kearns et al., 2008). In contrast, the presence of serum could slightly decrease the 
size of the lipoplexes (Han et al., 2008). 
 Conversely, some researchers have demonstrated that smaller lipoplexes were more 
efficient (Salvati et al., 2006). We studied the correlation between the size of the cationic 
lipids 6a-f/nucleic acid complexes and their TE (Medvedeva, et al., 2009). The ability of the 
cationic lipids to deliver plasmid DNA  is dependent upon the size of the lipids/DNA 
complexes formed in solution, which is consistent with that the maximum endocytosis by 
non-specialized cells requires that the particle size is below 100 nm (Chen et al., 2007). The 
lipid 6a formed the smallest complexes with the plasmid DNA, characterized by a narrow 
size distribution; this lipid exhibited the highest TE. The lipids 6b and 6d formed with 
plasmid DNA the complexes with a wide size distribution and a large fraction of small 
particles inferior to 50 nm; these lipids display moderate TE. A reduction in   the size of 
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liposomes, might facilitate their penetration through the physiological barriers, after the 
administration in vivo, in addition to  the possibility  of passively targeting the tumor sites, 
which is facilitated by the enhanced permeability of blood vessels and retention (EPR) effect 
(Gullotti & Yeo, 2009).  
It was demonstrated that the size of latex particles has a significant effect upon the efficiency 
of cell uptake and the mode of the endocytic pathway (Rejman et al., 2004).  Particles that 
have a size of 500 nm penetrated into the cell via the caveolae-mediated endocytosis. On the 
contrary, the microspheres having a diameter of 200 nm or less and preferred the clathrin-
mediated endocytosis, were found to accumulate in the lysosomal compartment. The precise 
control of the size of lipoplexes is important for further intracellular fate of lipoplexes that 
determine by-turn their transfection efficiencies (Rejman et al., 2006). 
3.2 Influence of surface charge 
The colloidal stability of the lipoplexes is determined by the surface charged of the particles, 
which can be expressed as zeta potential (ξ-potential). The value of ξ-potential can be 
changed from negative to positive depending on the N/P ratio (ratio describing the number 
of the negatively-charged phosphate groups of the nucleic acid to the positively charged 
groups of the amphiphile). N/P ration contributes significantly to the delivery of nucleic 
acids into cells. The complexes having a neutral charge are usually characterized by a large 
size and a low TE, as a result of a tendency to form aggregates and to precipitate (Salvati et 
al., 2006). A small redundant positive charge of the lipoplexes facilitates the efficient 
interaction with the negatively charged components of the cell membrane, as well as the 
transport via the cell membrane.  
A direct correlation was observed between the value of ξ-potential and TE, when studying 
the transfection in vitro. It was demonstrated that the cationic liposomes formed by lipid 2а 
had the highest ζ-potential in comparison with liposomes formed by lipids 1a,b, 2b,с and 3а, 
and exhibited the highest TE with respect to HeLa, COS-7, and NIH 3T3 cells (Takeuchi et 
al., 1996). However the dependence of the structure of the lipid, ξ-potential and the TE was 
not always obvious (Kearns et al., 2008; Malaekeh-Nikouei et al., 2009).  
3.3 Influence of physico-chemical parameters on the TE in vivo 
The low transfection efficiency in vivo is one of factors that hinders the design of  an efficient 
liposomal gene delivery systems. Negatively charged components of serum could interact 
with cationic liposome and compete with DNA for cationic liposome binding, leading to a 
decrease in TE. Other destructive effects of serum components attributed to its interaction 
with lipoplexes and early release of DNA from lipid shielding bilayer that reduces the TE. 
Moreover, the released nucleic acids could be recognized by Toll-like receptor expressed in 
B cells and dendritic cells; resulting in toxicity via induction of the cytokine production 
(Tousignant et al., 2000). Lipoplexes were reported to be generally more than 100 nm in 
diameter, as well as tend to self-aggregate in the blood stream, which resulting in limited 
passage through the vessel walls (Pouton & Seymour, 2001).  
The difference between the optimal transfection parameters of in vitro and in vivo due to the 
profound difference of the biochemical characteristics between the cells and the organism, is  
the most severe problem associated with the use and practical implementation of cationic 
lipid or liposomes for the treatment of genetic and acquired diseases. In the case of 
monocationic lipids there is a single reference that the in vivo result corresponded to the in 
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vitro one (Ding et al., 2008) and positively charged lipoplexes are significantly more effective 
than negatively charged ones. Other investigations revealed that the best TE in vivo 
corresponds to a low N/P ratio, small size of lipoplexes, and negative ξ-potential (Hattori et 
al., 2007; Gao & Hui, 2001). It is noteworthy when considering polycationic lipids, that 
lipoplexes that have a total negative charge and small size (200–300 nm) are optimal for both 
in vitro and in vivo transfection. (Stewart et al., 2001). 
It was revealed  that the efficient gene delivery by polycationic lipids (Cooper et al., 1998) in 
vivo requires the cationic liposome systems, which  are able to bind DNA more tightly than 
for the in vitro delivery. In comparison to CDAN(18d)/DOPE and DC-Chol(1a)/DOPE 
liposomes, CTAP(18g)/DOPE was able to neutralize, condense and encapsulate nucleic 
acids into lipoplex particles with a high efficiency. SDS stimulated the DNA release from a 
lipoplex and revealed the structure-activity relationships between the TE and lipid shielding 
of DNA (Bajaj et al., 2008c). Low shielding could facilitate the release of DNA and its 
hydrolysis within the cells. Certainly, this characteristic could be expected to be useful in 
vivo, given the greater complexity of the extracellular environment in vivo as compared to in 
vitro. Caminiti and co-workers demonstrated that both unstable and lipoplexes that are too 
stable, result in a strong and poor DNA release respectively, and exhibit a low transfection 
efficiency (Caracciolo et al., 2007). 
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